InvestLog
ACRV Acrivon Therapeutics, Inc. Common Stock logo

ACRV Acrivon Therapeutics, Inc. Common Stock

Healthcare
$1.71+0.00%OpenMarket Cap: $53.9M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

16

Dispositions

7

Buy/Sell Ratio

2.29

Net Shares

+4,464,256

Shares Acquired

4,467,857

Shares Disposed

3,601

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20TOMSICEK MICHAEL JOHNdirectorSell9,366$0.009,366
Wed May 20Shacham SharondirectorSell9,366$0.009,366
Wed May 20RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Sell9,366$0.009,366
Wed May 20Peterson Katharineofficer: Chief Accounting OfficerSell14,227$0.0018,134
Wed May 20Palani SanthoshdirectorSell9,366$0.009,366
Wed May 20Mirza Mansoor Razaofficer: Chief Medical OfficerSell38,817$0.0038,817
Wed May 20Miller Maryofficer: Chief Legal OfficerSell49,830$0.0082,767
Wed May 20Magovcevic-Liebisch IvanadirectorSell9,366$0.009,366
Wed May 20DiRocco DerekdirectorSell9,366$0.009,366
Wed May 20BAUM CHARLES MdirectorSell9,366$0.009,366
Mon May 18Peterson Katharineofficer: Chief Accounting OfficerSell99$1.923,907
Mon May 18Miller Maryofficer: Chief Legal OfficerSell184$1.9232,937
Mon May 18Gamelin Erickofficer: Chief Development OfficerSell404$1.9214,408
Mon May 18Devroe Ericofficer: Chief Operating OfficerSell613$1.9273,972
Mon May 18Blume-Jensen Peterdirector, officer: President and CEOSell1,253$1.922,078,951